Clinicopathologic characteristics of patients with nonsmall cell lung carcinoma with elevated serum progastrin‐releasing peptide levels

BACKGROUND Progastrin‐releasing peptide (proGRP) is a specific tumor marker in patients with small cell lung carcinoma (SCLC). It has been reported that serum proGRP levels rarely are elevated in patients with nonsmall cell lung carcinoma (NSCLC); the reported frequency is

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer 1998-03, Vol.82 (6), p.1056-1061
Hauptverfasser: Goto, Koichi, Kodama, Tetsuro, Hojo, Fumihiko, Kubota, Kaoru, Kakinuma, Ryutaro, Matsumoto, Taketoshi, Ohmatsu, Hironobu, Sekine, Ikuo, Nagai, Kanji, Nishiwaki, Yutaka
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:BACKGROUND Progastrin‐releasing peptide (proGRP) is a specific tumor marker in patients with small cell lung carcinoma (SCLC). It has been reported that serum proGRP levels rarely are elevated in patients with nonsmall cell lung carcinoma (NSCLC); the reported frequency is
ISSN:0008-543X
1097-0142
DOI:10.1002/(SICI)1097-0142(19980315)82:6<1056::AID-CNCR7>3.0.CO;2-C